Denali Therapeutics Inc. DNLI Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s operating lease liabilities?
- Denali Therapeutics Inc. (DNLI) reported operating lease liabilities of $24.68M in Q1 2026.
- How has Denali Therapeutics Inc.'s operating lease liabilities changed year-over-year?
- Denali Therapeutics Inc.'s operating lease liabilities decreased by 28.4% year-over-year, from $34.45M to $24.68M.
- What is the long-term trend for Denali Therapeutics Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s operating lease liabilities has grown at a -15.8% compound annual growth rate (CAGR), from $64.18M to $27.21M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.